Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ADVB

Advanced Biomed Inc

Feb 06 • 04:00PM ET

0.2319

-0.0071 -2.97 %

Healthcare • Diagnostics & Research • Taiwan • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.00	Insider Own	72.86%	Shs Outstand	21.64M	Perf Week	-23.19%
Market Cap	5.02M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.87M	Perf Month	-33.95%
Enterprise Value	4.99M	PEG	-	EPS next Q	-	Inst Own	1.22%	Short Float	4.12%	Perf Quarter	-47.63%
Income	-0.11M	P/S	-	EPS this Y	-	Inst Trans	64.97%	Short Ratio	0.43	Perf Half Y	-38.99%
Sales	0.00M	P/B	50.97	EPS next Y	-	ROA	-61.13%	Short Interest	0.24M	Perf YTD	-20.53%
Book/sh	0.00	P/C	55.78	EPS next 5Y	-	ROE	-158.97%	52W High	4.10 -94.34%	Perf Year	-
Cash/sh	0.00	P/FCF	-	EPS past 3/5Y	10.70% -11.88%	ROIC	-100.85%	52W Low	0.23 0.35%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	10.05% 10.61%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-4.26%	Oper. Margin	-	ATR (14)	0.03	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.92	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	30.12	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	1.92	EPS Q/Q	-50.00%	SMA20	-23.90%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.60	Sales Q/Q	-	SMA50	-32.53%	Rel Volume	0.05	Prev Close	0.24
Employees	31	LT Debt/Eq	0.10	Earnings	-	SMA200	-62.47%	Avg Volume	556.11K	Price	0.23
IPO	Mar 06, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	27,342	Change	-2.97%

Dec-31-25 10:25AM	Advanced Biomed sells Hong Kong subsidiary for $23,000 (TipRanks) -13.82%
Dec-30-25 10:17AM	Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary (GlobeNewswire)
Sep-19-25 08:30AM	Advanced Biomed Inc. Announces Launch of A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery (GlobeNewswire) -17.18%
Mar-07-25 12:29PM	Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering (GlobeNewswire)
Mar-06-25 09:02AM	Advanced Biomed Inc. Announces Pricing of Initial Public Offering (GlobeNewswire)

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. It engages in the research & development of microfluidic biochip technologies and provides tumor diagnosis and treatment technology applications. The company was founded by Yi Lu and Steven I-Fang Cheng in 2014 and is headquartered in Tainan, Taiwan.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADVB

Advanced Biomed Inc

Upgrade your FINVIZ experience